Ken Griffin acquired 11.4 Thousand Beam Therapeutics shares worth $389 Thousand. That's 0.00% of their equity portfolio (3654th largest holding). The first Beam Therapeutics trade was made in Q1 2020. Since then Ken Griffin bought shares eight more times and sold shares on six occasions. The investor's estimated purchase price is $539 Thousand, resulting in a loss of 28%.